Table 5.
Death predicting factors of in-hospital mortality in patients with stroke.
| Survival | Death | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| N (%) | N (%) | OR (95% CI) | P | OR (95% CI) | P | |
| Sex | ||||||
| Female | 85 (68.5) | 39 (31.5) | 0.75 (0.49–1.14) | 0.18 | 0.72 (0.23–2.19) | 0.56 |
| Male | 153 (76.1) | 48 (23.9) | ||||
| Age (years) | ||||||
| <45 | 31 (68.9) | 14 (31.1) | ||||
| 45–54 | 58 (77.3) | 17 (22.7) | 0.68 (0.33–1.42) | 0.32 | ||
| 55–64 | 71 (71) | 29 (29) | 0.85 (0.45–1.61) | 0.62 | ||
| ≥65 | 78 (74.3) | 27 (25.7) | 0.80 (0.42–1.52) | 0.51 | ||
| Time 1* | ||||||
| ≤6 hours | 147 (71) | 60 (29) | 0.77 (0.49–1.21) | 0.27 | ||
| >6 hours | 91 (77.1) | 27 (22.9) | ||||
| Time 2** | ||||||
| ≤6 hours | 66 (75.9) | 21 (24.1) | 1.13 (0.69–1.85) | 0.63 | ||
| >6 hours | 172 (72.3) | 66 (27.7) | ||||
| Comorbidities*** | ||||||
| HBP | 167 (73.6) | 60 (26.4) | 0.91 (0.58–1.43) | 0.68 | ||
| Diabetes | 50 (74.6) | 17 (25.4) | 0.94 (0.56–1.60) | 0.83 | ||
| Dyslipidemia | 26 (89.7) | 3 (10.3) | 0.35 (0.11–1.12) | 0.08 | 0.5 (0.06–4.13) | 0.52 |
| Stroke§ | 31 (81.6) | 7 (18.4) | 0.62 (0.29–1.34) | 0.20 | 0.46 (0.09–2.16) | 0.33 |
| Alcohol | 80 (87) | 12 (13) | 0.34 (0.18–0.62) | 0.0001 | 0.43 (0.12–1.58) | 0.21 |
| Tobacco | 48 (92.3) | 4 (7.7) | 0.23 (0.08–0.62) | 0.004 | 1.02 (0.16–6.52) | 0.99 |
| HIV | 8 (80) | 2 (20) | 0.67 (0.16–2.71) | 0.57 | ||
| Glasgow, (/15) | ||||||
| ≤8 | 10 (18.2) | 45 (81.8) | 9.34 (6.08–14.33) | 0.0001 | 13.41 (4.86–36.9) | 0.0001 |
| >8 | 228 (84.4) | 42 (15.6) | ||||
| Temperature (°C) | ||||||
| ≤37.5 | 196 (80.3) | 48 (19.7) | 2.78 (1.82–4.25) | 0.0001 | 2.17 (0.76–6.23) | 0.15 |
| >37.5 | 42 (51.9) | 39 (48.1) | ||||
| Glycemia (g/L) capillary | ||||||
| ≤1.4 | 150 (79.4) | 39 (20.6) | 1.87 (1.19–2.92) | 0.007 | 3.61 (1.38–9.44) | 0.009 |
| >1.4 | 68 (64.8) | 37 (35.2) | ||||
| Serum creatinine (mg/L) | ||||||
| ≤13 | 152 (80.9) | 36 (19.1) | 1.74 (1.08–2.80) | 0.02 | 0.75 (0.19–3.02) | 0.69 |
| >13 | 66 (67.3) | 32 (32.7) | ||||
| Urea (g/L) | ||||||
| ≤0.45 | 152 (81.3) | 36 (18.7) | 1.79 (1.07–2.98) | 0.02 | 1.57 (0.41–6.08) | 0.51 |
| >0.45 | 52 (66.7) | 26 (33.3) | ||||
| CRP (mg/L) | ||||||
| <6 | 77 (92.8) | 6 (7.2) | ||||
| 6–24 | 39 (83) | 8 (17) | 1.79 (0.62–5.19) | 0.29 | 1.03 (0.24–4.36) | 0.97 |
| >24 | 35 (71.4) | 14 (28.6) | 2.67 (1.01–7.08) | 0.048 | 0.89 (0.23–3.4) | 0.87 |
| Uric acid (mg/L) | ||||||
| ≤70 | 35 (87.5) | 5 (12.5) | 1.68 (0.49–5.80) | 0.41 | ||
| >70 | 59 (92.2) | 5 (7.8) | ||||
| Complications during admission | 70 (66.7) | 35 (33.3) | 1.06 (0.62–1.81) | 0.41 | ||
| Stroke's type | ||||||
| Ischemic | 148 (87.1) | 22 (12.9) | 3.32 (2.05–5.40) | 0.0001 | 5.65 (1.77–18.02) | 0.003 |
| Hemorrhagic | 90 (58.1) | 65 (41.9) | ||||
Time 1: delay from stroke onset and the first consultation; Time 2: delay from stroke onset and consultation at Douala General Hospital.
Comorbidities: known vascular risk factors during admission; HBP: high blood pressure; §past medical history of stroke.